Leupin Nicolas — SEC Form 4 filings

SEC reporting owner CIK 2007766. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-29 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NovoCure Ltd (NVCR)Former Chief Medical Officer66 legs · 4,111 sh · $68,3834

Form 4 filings — Leupin Nicolas

FiledFormIssuerReported transactionsSource
2026-03-054NovoCure Ltd (NVCR)Sale (S): 1,100 @ $13.31EDGAR
2026-03-034NovoCure Ltd (NVCR)Sale (S): 1,029 @ $13.66EDGAR
2025-03-064NovoCure Ltd (NVCR)Grant/award (A): 54,975 @ $18.19 · Grant/award (A): 81,499 (derivative) @ $18.19EDGAR
2025-03-034/ANovoCure Ltd (NVCR)Sale (S): 830 @ $19.92 · Sale (S): 161 @ $20.55EDGAR
2025-03-034NovoCure Ltd (NVCR)Sale (S): 830 @ $19.92 · Sale (S): 161 @ $20.55EDGAR
2024-02-294NovoCure Ltd (NVCR)Grant/award (A): 51,124 @ $16.30 · Grant/award (A): 78,174 (derivative) @ $16.30EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2007766 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →